Cargando…

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection

Patients with chronic lymphocytic leukemia (CLL) show suboptimal responses to the vaccines against SARS-CoV-2; it has been shown though that a booster dose of the BNT162b2 vaccine may lead to a significant increase in the seroconversion rates of immunocompromised patients. We conducted a prospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diamantopoulos, Panagiotis T., Kontandreopoulou, Christina-Nefeli, Stafylidis, Christos, Vlachopoulou, Dimitra, Giannakopoulou, Nefeli, Vardaka, Maria, Mpouhla, Anthi, Variami, Eleni, Galanopoulos, Athanasios, Pappa, Vassiliki, Psichogiou, Mina, Hatzakis, Angelos, Viniou, Nora-Athina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589533/ https://www.ncbi.nlm.nih.gov/pubmed/36271935 http://dx.doi.org/10.1007/s00277-022-05003-6

Ejemplares similares

Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
por: Kontandreopoulou, Christina-Nefeli, et al.
Publicado: (2021)

The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia
por: Chatzidavid, Sevastianos, et al.
Publicado: (2023)

Bacillus Cereus in Hematological Malignancies
por: Markouli, Mariam, et al.
Publicado: (2022)

The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
por: Kontandreopoulou, Christina-Nefeli, et al.
Publicado: (2022)

Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma: A case report and review of the literature
por: Spetsieris, Nikolaos, et al.
Publicado: (2018)

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis
por: Charakopoulos, Emmanouil, et al.
Publicado: (2020)

PB1992: PROTEOMIC ANALYSIS REVEALS AUTOPHAGY INHIBITION IN MYELODYSPLASTIC SYNDROMES
por: Tsekoura, Georgia, et al.
Publicado: (2023)

A Patient with Synchronous Gallbladder and Bone Plasmacytoma
por: Markouli, Mariam, et al.
Publicado: (2023)

Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein–Barr virus‐positive patients with chronic lymphocytic leukemia
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2016)

Deregulation of Autophagy and Apoptosis in Patients with Myelodysplastic Syndromes: Implications for Disease Development and Progression
por: Tsekoura, Georgia, et al.
Publicado: (2023)

A case report of a very late response to 5-azacytidine in a patient with lower risk myelodysplastic syndrome: Time to update treatment guidelines for lower risk patients
por: Spetsieris, Nikolaos, et al.
Publicado: (2018)

An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia
por: Iliakis, Theodoros, et al.
Publicado: (2014)

JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature
por: Chatzidavid, Sevastianos, et al.
Publicado: (2021)

Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study
por: Papadokostaki, Eleni, et al.
Publicado: (2022)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Modelling SARS-CoV-2 Binding Antibody Waning 8 Months after BNT162b2 Vaccination
por: Hatzakis, Angelos, et al.
Publicado: (2022)

Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)
por: Kotsianidis, Ioannis, et al.
Publicado: (2019)

Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection
por: Psichogiou, Mina, et al.
Publicado: (2021)

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2021)

Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
por: Psichogiou, Mina, et al.
Publicado: (2021)

Treatment Engagement of Psychotic Patients with a Mobile Mental Health Unit in Rural Areas in Greece: A Five-Year Study
por: Peritogiannis, Vaios, et al.
Publicado: (2013)

Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
por: Herishanu, Yair, et al.
Publicado: (2022)

Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8(+) T cell immunity in CLL and MDS patients
por: Hernandez, Susana Patricia Amaya, et al.
Publicado: (2023)

Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study
por: Liapis, Konstantinos, et al.
Publicado: (2020)

An unusual case report of unilateral parotid gland sarcoidosis with spontaneous remission
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2019)

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

Transmission Dynamics of Carbapenemase-Producing Klebsiella Pneumoniae and Anticipated Impact of Infection Control Strategies in a Surgical Unit
por: Sypsa, Vana, et al.
Publicado: (2012)

Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis
por: Lagopati, Nefeli, et al.
Publicado: (2021)

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
por: Diamantopoulos, Panagiotis, et al.
Publicado: (2019)

Acute Lymphoblastic Leukemia and Invasive Mold Infections: A Challenging Field
por: Stafylidis, Christos, et al.
Publicado: (2022)

Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers
por: Syrimi, Natalia, et al.
Publicado: (2023)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

PARP1-Driven Apoptosis in Chronic Lymphocytic Leukemia
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2014)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0i1i4p1osu2bicqflj24p3qh20